Caterina De Sarro
Catanzaro, 88100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Real‑world safety and efficacy of biological agents in inflammatory bowel disease: a one-year post-marketing pharmacovigilance observational study in the Calabria region.
Journal: Pharmacological reports : PR
Published: April 11, 2025
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis.
Journal: Pharmaceutics
Published: September 26, 2024
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy.
Journal: European journal of pharmacology
Published: August 30, 2023
A new emergency during the latest phase of the COVID-19 pandemic: access to healthcare services by patients with non-communicable diseases.
Journal: Frontiers in medicine
Published: July 20, 2023
Ranolazine Attenuates Brain Inflammation in a Rat Model of Type 2 Diabetes.
Journal: International journal of molecular sciences
Published: October 29, 2022
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study.
Journal: Pharmaceutics
Published: October 14, 2022
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region.
Journal: Pharmaceutics
Published: September 30, 2022
Liraglutide chronic treatment prevents development of tolerance to antiseizure effects of diazepam in genetically epilepsy prone rats.
Journal: European journal of pharmacology
Published: February 08, 2022
Last Updated: 09/26/2026